Peter Casella, MD
Obstetrics & Gynecology · Kissimmee, FLNPI 1245200278
Payments from drug & device makers
What this record shows
This record is dominated by education: $10,525 of the $17,228 with a category attached, or 61.1%. Intuitive Surgical accounts for 61.1% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2022 at $11,078 and has fallen 99.6% since, to $42 in 2025. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $142.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- AbbVie$3K
- Minerva Surgical, Inc$1K
- Olympus Corporation Of The Americas$698
- Hologic Sales And Service, LLC$418
- Therapeuticsmd, Inc.$216
- plus $2K from 23 others
Across 171 payments — averaging $4256.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sumitomo Pharma America, Inc.$365K
- AbbVie$328K
- GSK$34K
What the payments were for
- Speaking & faculty fees$3,17518%
- Travel & lodging$6984%
- Food & beverage$2,83016%
- Education$10,52561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $10,531 |
| AbbVie(2 entities) | 15 | $2,642 |
| Minerva Surgical, Inc | 3 | $1,072 |
| Olympus Corporation Of The Americas | 7 | $698 |
| Hologic Sales And Service, LLC | 5 | $418 |
| Therapeuticsmd, Inc. | 23 | $216 |
| Vertical Pharmaceuticals, LLC | 14 | $211 |
| Meditrina | 6 | $161 |
| Merz North America, Inc. | 3 | $149 |
| Bard Access Systems, Inc. | 2 | $140 |
| Roche Diagnostics Corporation | 1 | $107 |
| Pacira Pharmaceuticals Incorporated | 1 | $100 |
| Gynesonics, Inc. | 1 | $93 |
| Allotrope Medical, Inc | 1 | $79 |
| Myovant Sciences Inc. | 4 | $78 |
| IBSA Pharma Inc. | 5 | $69 |
| Millicent US Inc | 3 | $61 |
| Channel Medsystems, Inc. | 1 | $59 |
| Pfizer | 3 | $58 |
| Astellas Pharma US Inc | 2 | $52 |
| Lupin Inc. | 3 | $48 |
| Mimedx Group, Inc. | 2 | $42 |
| Avion Pharmaceuticals | 3 | $42 |
| Ascend Therapeutics US, LLC | 2 | $25 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Dysis Medical, Inc. | 1 | $13 |
| Olympus America Inc. | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$10,500
- ORIAHNN$2,229
- Minerva ES$1,050
- Genesys HTA$1,050
- SYMPHION$1,050
- Resectr$1,050
- Olympus$536
- ACESSA PROVU SYSTEM$269
- PROGEL$124
- BIJUVA$119
- XEOMIN$118
- ASCLERA$118
- Orilissa$110
- RS Harmony Test Related Products$107
- DIVIGEL$103
- EXPAREL$100
How this compares
$17,228 in reported general payments places this provider in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 20 | $7,017 |
| LinzessLinaclotide | 11 | $6,997 |
| Estradiol | 191 | $4,726 |
| Estradiol (Once Weekly)Estradiol | 11 | $636 |
| Fluconazole | 29 | $546 |
| Oxybutynin Chloride ErOxybutynin Chloride | 26 | $183 |
| Ciprofloxacin Hcl | 16 | $134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $58 | $7,01720 claims |
| AbbVieLinzess | $2,642 | $6,99711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Kissimmee
- Mark PalazzoloKissimmee$54K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.